Captor Therapeutics obtained funding to start three out of five R&D projects focused on the development of new therapeutics and candidates for drugs.
1. "Development of the platform for the identification of a first-in-class allosteric modulators" co-financed by European Regional Development Fund through POIR program for years 2014-2020 NCBR, measure 4.1 "Research and development", sub-measure 4.1.2 "Regional research agendas" (collaboration with Institute of Immunology and Experimental Therapy, Polish Academy of Sciences). Project Number: POIR.04.01.02-00-0147/16
2. "Development and implementation of an innovative platform for the identification drug-like compounds" co-financed by European Regional Development Fund through POIR program for years 2014-2020 NCBR, measure 4.1 "Research and development", sub-measure 4.1.4 "Application projects" (collaboration with EIT+ Wroclaw Research Center). Project number: POIR.04.01.04-00-0116/16
3. "Development of first-in-class anti-inflammatory drugs specifically degrading cell surface receptors" co-financed by European Regional Development Fund through POIR program for years 2014-2020 NCBR, measure 1.1 "R&D projects of enterprises", sub-measure 1.1.1 "Industrial research and development work implemented by enterprises". Project number: POIR.01.01.01-00-0747/16.
